Compare
Vumerity vs. Bafiertam

Vumerity, also known by its generic name dimethyl fumarate, is approved in adults for treating relapsing forms of multiple sclerosis (MS). It belongs to the drug class called fumaric acid derivatives. Vumerity (diroximel fumarate) is a capsule that's taken by mouth twice per day. The most common side effects are stomach upset and flushing (e.g., facial warmth, redness, burning sensation).

• Relapsing forms of multiple sclerosis (MS)

• Flushing (40%)
• Stomach pain (18%)
• Diarrhea (14%)
• Nausea (12%)

• Severe allergic reaction
• Flushing
• Risk for serious infections
• Low white blood cell counts (lymphopenia)
• Liver damage
• Serious stomach and gut problems

Bafiertam (monomethyl fumarate) is an oral medication that's FDA approved to treat multiple sclerosis (MS) in adults. It's a type of disease-modifying therapy for MS. This multiple sclerosis treatment is a capsule that's taken by mouth twice a day. Common side effects include flushing, stomach pain, and diarrhea. Bafiertam (monomethyl fumarate) is a brand-name medication only; there isn't a generic version yet.

• Relapsing forms of multiple sclerosis

Note: Side effects were reported by people taking a similar medication called dimethyl fumarate (Tecfidera).

• Flushing (40%)
• Stomach pain (18%)
• Diarrhea (14%)
• Nausea (12%)

• Serious allergic reactions
• Risk of brain infection (progressive multifocal leukoencephalopathy)
• Risk of other serious infections
• Low white blood cell counts (lymphopenia)
• Liver injury
• Serious stomach problems